histiocytic sarcoma (Cancer)
Information
- Disease name
- histiocytic sarcoma
- Disease ID
- DOID:0080915
- Description
- "A histiocytic and dendritic cell cancer that is characterized by the presence of neoplastic cells with morphologic and immunophenotypic characteristics similar to those seen in mature histiocytes." [url:https\://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520642/]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03155620 | Recruiting | Phase 2 | Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) | July 31, 2017 | September 30, 2027 |
| NCT04079179 | Recruiting | Phase 2 | Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders | April 19, 2021 | December 2029 |
| NCT03316573 | Suspended | Phase 2 | Pembrolizumab in Neoplasms or Lymphomas | December 7, 2017 | August 18, 2024 |
| NCT03651375 | Unknown status | Phase 2 | Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall | February 11, 2017 | March 2022 |
- Disase is a (Disease Ontology)
- DOID:5621
- Cross Reference ID (Disease Ontology)
- ICDO:9755/3
- Cross Reference ID (Disease Ontology)
- MESH:D054747
- Cross Reference ID (Disease Ontology)
- NCI:C27349
- ICD10 preferred id (Insert disease from ICD10)
- id-SRFSFto-be-added-later-1249313223700-7
- ICD10 class code (Insert disease from ICD10)
- C96.8
- MeSH unique ID (MeSH (Medical Subject Headings))
- D054747